Molson Coors Brewing Company
TAP
$41.67
+5.57%
Molson Coors Beverage Company is the second-largest brewer in the US, Canada, and the UK, producing and marketing beer brands including Coors, Miller, Blue Moon, and Carling, while also distributing partner brands such as Heineken, Coca-Cola, and Fever-Tree through licensing agreements; North America accounts for roughly 80% of revenue. The company is a mature, cash-generative consumer staples operator with a defensive portfolio and a deep distribution moat, but it operates in a structurally challenged alcoholic beverage category facing secular volume declines. The investor narrative is dominated by a growth hangover in beer, evidenced by a 3.3% year-over-year revenue decline in the most recent quarter and a Q4 2025 earnings miss that sent shares lower on disappointing guidance. A massive $60 billion all-stock spirits merger in the industry has reinforced the theme of defensive consolidation amid slowing consumer demand and fading pricing power, while peers such as Anheuser-Busch show early signs of volume stabilization that investors are watching for read-through to TAP. The stock's deep value multiple, 4.1% dividend yield, and depressed price sit against a backdrop of negative trailing earnings from a large impairment, keeping the debate centered on whether volumes can trough before the dividend and balance sheet come under pressure.…
TAP
Molson Coors Brewing Company
$41.67
Related headlines
Investment Opinion: Should I buy TAP Today?
Rating: Hold. The core thesis is that TAP is a deeply discounted, cash-generative staples operator whose 4.13% dividend and 0.82x sales multiple offer a margin of safety, but contracting revenue and margin compression prevent a Buy until volumes trough. The analyst consensus of Hold (mean 2.76) with an average target of $44.05, implying +11.5% upside, anchors this balanced view.
Supporting evidence includes the 8.18x forward PE against consensus EPS of $6.16, the 0.82x PS ratio at the bottom of its historical 2.36x-5.52x range, and TTM free cash flow of $1.326 billion that comfortably covers the $90.1 million quarterly dividend. However, revenue growth of -3.26% and a 571-basis-point gross margin decline offset the valuation appeal, and the 4.13% yield is not covered by reported EPS given the negative payout ratio. The 0.89x price-to-book and 5.10x price-to-cash-flow ratios confirm the deep-value positioning.
The biggest risks are a continued volume decline, a dividend cut, and a breakdown below the $35.52 52-week low. This Hold would upgrade to Buy if gross margin stabilizes above 38% and revenue growth turns positive, or downgrade to Sell if revenue declines accelerate below -5% or the dividend is cut. Relative to its history and peers, TAP is undervalued on sales and book, but the discount is partly justified by negative growth and margin pressure, making it fairly valued for a no-growth staples name rather than a compelling bargain.
Sign up to view all
TAP 12-Month Price Forecast
TAP is a deep-value staples name caught between a covered dividend and a contracting top line. The 0.82x sales multiple and 8.18x forward PE already discount persistent volume declines, limiting further downside, while the 4.13% yield and $1.326 billion free cash flow provide income support. Analyst sentiment is neutral (Hold, 2.76 mean) with a wide $33-$61 target range, reflecting binary outcomes around the next earnings print. I would upgrade to bullish if gross margin stabilizes above 38% and revenue growth turns positive, and downgrade to bearish if revenue declines accelerate below -5% or the dividend is cut.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Molson Coors Brewing Company's 12-month outlook, with a consensus price target around $43.67 and implied upside of +4.8% versus the current price.
Average Target
$43.67
0 analysts
Implied Upside
+4.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$33 - $61
Analyst target range
Coverage is broad with 21 analysts, and the consensus recommendation is a Hold with a mean rating of 2.76 on a scale where 1 is a strong buy and 5 is a strong sell. The average target price is $44.05, implying roughly +11.5% upside from the current $39.52, a modest return that is roughly in line with the 4.13% dividend yield and does not suggest a high-conviction bullish call. The consensus leans neutral-to-cautious, consistent with the recent institutional ratings flow showing repeated Neutral and Equal Weight reiterations from JP Morgan, Piper Sandler, UBS, Citigroup, Wells Fargo, and Morgan Stanley, alongside a Barclays Underweight and a lone Needham Buy. The target range is wide, from a low of $33.00 (about -16.5% downside) to a high of $61.00 (about +54.4% upside), a spread of $28 that signals meaningful disagreement about the trajectory of volumes and margins. The high target likely assumes a volume trough, margin recovery toward the 40% gross margin level, and multiple re-rating from deeply depressed levels, while the low target prices in continued volume declines, margin compression, and a dividend that becomes harder to defend. The absence of any recent upgrades and the clustering of Neutral ratings indicate analysts are waiting for evidence of stabilization rather than positioning ahead of it, and the wide dispersion means position sizing should account for binary outcomes around the next earnings print.
Bulls vs Bears: TAP Investment Factors
The bear case currently has stronger evidence: revenue is contracting 3.3%, gross margin has compressed 571 basis points year over year, and the stock has underperformed the S&P 500 by 31.52 percentage points over one year. The bull case rests on deep value (0.82x sales, 8.18x forward PE), a covered 4.13% dividend, and a low beta of 0.43 that supports risk-adjusted positioning. The single most important tension is whether volumes can trough before the dividend and balance sheet come under pressure; a stabilization in North American beer volumes would validate the value thesis, while continued declines would confirm the value-trap narrative. Analyst consensus (Hold, $44.05 average target) reflects this standoff, with the wide $33-$61 target range capturing binary outcomes around the next earnings print.
Bullish
- Deep value on sales and book: TAP trades at 0.82x sales and 0.89x book, far below the 2x-4x sales multiples typical of branded consumer staples. The PS ratio sits at the very bottom of its multi-year range of roughly 2.36x to 5.52x, implying the market has already priced in persistent volume declines.
- Cash flow comfortably covers dividend: TTM free cash flow of $1.326 billion easily covers the $90.1 million quarterly dividend and $103.5 million of Q2 capex. The 4.13% dividend yield is backed by real cash generation, not just accounting earnings, and Q2 operating cash flow of $817.9 million against $1.493 billion of debt repayment shows active deleveraging.
- Forward PE of 8.18x implies earnings normalization: Consensus EPS of $6.16 against a $39.52 price yields a forward PE of 8.18x, a steep discount to the high-teens multiples staples peers often command. The gap between the negative trailing PE of -4.31x and the forward PE signals the market expects the impairment-driven loss to be non-recurring.
- Low beta and mean-reversion setup: Beta of 0.43 means TAP is roughly 57% less volatile than the market, supporting larger risk-adjusted position sizing. The stock has bounced 9.9% from its late-September low of $35.95 to $39.52, and the 1-month change of +1.05% suggests selling pressure is decelerating.
Bearish
- Revenue contracting 3.3% year over year: Q2 2026 revenue of $3.097 billion fell 3.26% from $3.201 billion a year earlier, extending a pattern of softness across Q1 and Q4 2025. For a defensive staples name, negative top-line growth forces margin defense through cost cuts rather than growth, undermining the investment case.
- Gross margin compression is severe: Gross margin fell from 40.05% in Q2 2025 to 34.34% in Q2 2026, a 571-basis-point decline that suggests input costs, mix, or promotional spending are eroding prior pricing gains. This is the key watch item because it directly threatens the earnings base that justifies the forward PE.
- Trailing loss and negative ROE distort valuation: A Q3 2025 net loss of $2.928 billion from a $3.918 billion other-expense charge produced trailing EPS of -$0.23, a trailing net margin of -19.21%, and ROE of -20.91%. The negative payout ratio of -0.18 means dividend safety hinges on underlying earnings recovery rather than reported EPS.
- Thin liquidity and relative underperformance: The current ratio of 0.55 is well below 1.0, indicating limited short-term liquidity buffer. The stock has lagged the S&P 500 by 31.52 percentage points over one year and 28.55 points year-to-date, reflecting persistent distribution rather than accumulation.
TAP Technical Analysis
TAP is in a sustained downtrend, with a 1-year price change of -15.99% and a year-to-date decline of -16.62%, badly lagging the S&P 500's +15.53% one-year return for a relative strength gap of -31.52 percentage points. At the current price of $39.52, the stock sits at roughly 20.7% of its 52-week range of $35.52 to $54.82, positioning it near the lower end of the band where value buyers look for a floor but where momentum traders see a falling knife. The stock is 27.9% below its 52-week high and only 11.3% above its 52-week low, a positioning that reflects persistent distribution rather than accumulation. Short-term momentum has stabilized but not reversed: the 1-month change is +1.05%, slightly trailing the S&P 500's +1.22% for a relative strength of -0.17, while the 3-month change of -3.44% and 6-month change of -11.37% confirm the intermediate trend remains negative. The recent bounce from the late-September low of $35.95 to $39.52 represents a roughly 9.9% recovery, suggesting the selling pressure is decelerating even as the longer-term trend stays down. The 1-month positive print against a negative 1-year trend is a classic mean-reversion signal that requires confirmation through a higher low and improving volume. Key support sits at the 52-week low of $35.52, with the September closing low of $35.95 as the first line of defense; resistance is anchored at the 52-week high of $54.82, with intermediate supply likely near the $42-$43 area where the stock repeatedly failed in August. A breakout above $43 would signal a trend change and open a path toward the mid-$40s, while a breakdown below $35.52 would confirm the downtrend and likely trigger momentum-driven selling. The beta of 0.43 means the stock is roughly 57% less volatile than the market, which supports larger position sizing on a risk-adjusted basis but also means the stock will not rally sharply on broad market strength, and the max drawdown of -33.89% shows that low beta has not protected holders from severe sector-specific de-rating.
Beta
0.43
0.43x market volatility
Max Drawdown
-33.9%
Largest decline past year
52-Week Range
$36-$55
Price range past year
Annual Return
-10.6%
Cumulative gain past year
| Period | TAP Return | S&P 500 |
|---|---|---|
| 1m | +13.0% | -1.2% |
| 3m | +1.8% | +3.4% |
| 6m | -1.8% | +7.0% |
| 1y | -10.6% | +14.4% |
| ytd | -12.1% | +12.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
TAP Fundamental Analysis
Revenue is contracting: Q2 2026 revenue of $3.097 billion fell 3.26% year over year from $3.201 billion, extending a pattern of softness after Q1 2026 revenue of $2.351 billion and Q4 2025 revenue of $2.662 billion. The sequential and year-over-year declines point to volume pressure and limited pricing power in a category where consumers are trading down and drinking less beer, and the absence of segment data limits visibility into whether non-beer categories such as Coca-Cola licensed products are offsetting core beer weakness. For a defensive staples name, a negative 3.3% top-line trajectory is a meaningful red flag because it forces the company to defend margins through cost cuts rather than growth. Profitability is mixed: Q2 2026 net income was $231.7 million with a 7.48% net margin and a 34.34% gross margin, down from the 40.05% gross margin in Q2 2025, showing clear margin compression. The trailing figures are distorted by a Q3 2025 net loss of $2.928 billion driven by a $3.918 billion other-expense charge, which produced a trailing EPS of -$0.23 and a trailing net margin of -19.21%; excluding that impairment, the underlying business remains profitable with Q2 2026 operating income of $331.9 million and a 10.72% operating margin. The gross margin decline from 40.05% to 34.34% year over year is the key watch item, as it suggests input costs, mix, or promotional spending are eroding the pricing gains of prior years. The balance sheet is serviceable but not fortress-like: debt-to-equity is 0.62, the current ratio is a thin 0.55, and ROE is -20.91% on a trailing basis due to the impairment, though ROA is a positive 3.79%. Free cash flow TTM is $1.326 billion, which comfortably covers the $90.1 million quarterly dividend and the $103.5 million of Q2 capex, and the Q2 2026 cash flow statement shows $817.9 million of operating cash flow against $1.493 billion of debt repayment, indicating active deleveraging. The 4.13% dividend yield is attractive but the negative payout ratio of -0.18 reflects the trailing loss, so dividend safety hinges on the underlying earnings recovery rather than reported EPS.
Quarterly Revenue
$3.1B
2026-06
Revenue YoY Growth
-3.3%
YoY Comparison
Gross Margin
34.3%
Latest Quarter
Free Cash Flow
$1.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is TAP Overvalued?
Because trailing net income is negative (EPS of -$0.23, trailing PE of -4.31x), the PE ratio is not a valid primary metric; I am leading with the price-to-sales ratio of 0.82x and the EV/sales ratio of 1.21x, supplemented by the forward PE of 8.18x. The gap between the negative trailing PE and the 8.18x forward PE is enormous and implies the market expects a sharp earnings normalization, consistent with consensus EPS of $6.16, though the EV/EBITDA of -9.03x is distorted by the impairment and should be disregarded. A 0.82x sales multiple for a branded beverage company is deep-value territory and prices in persistent volume declines. Peer comparison is constrained because the provided valuation data does not include an industry average, but contextually a 0.82x PS and 0.89x price-to-book are well below the multiples typically commanded by branded consumer staples, which generally trade at 2x-4x sales. The 8.18x forward PE versus a staples sector that often trades in the high teens represents a substantial discount that is only partly justified by negative growth and margin compression; the market is effectively pricing TAP as a value trap. The 4.13% dividend yield and 5.10x price-to-cash-flow ratio suggest the cash generation is being valued cheaply relative to the earnings power. Historically, TAP's PS ratio has ranged from roughly 2.36x in Q2 2026 to 5.52x in Q1 2024, and the current 0.82x sits at the very bottom of that multi-year band, while the historical PE has swung from 5.6x to over 60x depending on impairment timing. The current valuation is near historical lows on both sales and book, which either signals a genuine value opportunity if volumes stabilize or reflects fundamental deterioration and a structurally lower earnings base; the burden of proof is on the company to show a revenue trough.
PE
-4.3x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 6x~39x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-9.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the revenue and margin trajectory. Q2 2026 revenue fell 3.26% year over year to $3.097 billion, and gross margin compressed from 40.05% to 34.34%, a 571-basis-point erosion that directly threatens the earnings base. The current ratio of 0.55 is thin, and while debt-to-equity of 0.62 is manageable, the negative payout ratio of -0.18 means the 4.13% dividend is not covered by reported EPS and depends on the $1.326 billion TTM free cash flow holding up. A large impairment produced trailing EPS of -$0.23 and ROE of -20.91%, and any further write-downs would compound the earnings volatility.
Market and competitive risks include valuation compression and secular category decline. At 0.82x sales and 8.18x forward PE, TAP is already priced as a value trap; if volumes fail to stabilize, the multiple could stay depressed or compress further, and the stock's 0.43 beta means it will not rally sharply on broad market strength. The $60 billion all-stock spirits merger signals defensive consolidation amid slowing consumer demand and fading pricing power, and Anheuser-Busch's return to volume growth could either validate a sector recovery or highlight TAP's relative share loss. Regulatory and macro headwinds, including consumer trading down and drinking less beer, add pressure.
The worst-case scenario is a continued volume decline that forces a dividend cut and triggers momentum-driven selling below the 52-week low of $35.52. From the current $39.52, a drop to the 52-week low represents roughly -10.1%, and a move to the analyst low target of $33.00 implies about -16.5%. The max drawdown of -33.89% shows that low beta has not protected holders from severe sector-specific de-rating, and a breakdown below $35.52 would confirm the downtrend and likely accelerate losses toward the low-$30s.
FAQ
The most severe risk is continued revenue decline: Q2 2026 revenue fell 3.26% year over year, and acceleration of that decline would undermine the earnings recovery implied by the 8.18x forward PE. Second is margin compression, with gross margin down from 40.05% to 34.34%, which directly threatens profitability and dividend coverage given the negative payout ratio of -0.18. Third is balance sheet and liquidity risk, with a current ratio of 0.55 and debt-to-equity of 0.62, limiting financial flexibility if cash flow deteriorates. Fourth is valuation compression and momentum risk, as the stock has underperformed the S&P 500 by 31.52 percentage points over one year and a break below $35.52 could trigger further selling.
The 12-month forecast has three scenarios: a 25% probability bull case targeting $54.82-$61.00 if volumes stabilize and margins recover, a 50% probability base case targeting $42.00-$46.00 around the analyst average of $44.05, and a 25% probability bear case targeting $33.00-$35.52 if declines accelerate. The base case is most likely, assuming revenue declines moderate to -1% to -3% and gross margin holds in the 34%-36% range, with free cash flow above $1.2 billion covering the dividend. The wide analyst target range of $33-$61 reflects genuine disagreement about the volume trajectory, and the next earnings print is the key binary event.
TAP is undervalued on sales and book, trading at 0.82x PS and 0.89x PB versus historical ranges of roughly 2.36x-5.52x for PS and typical staples multiples of 2x-4x sales. The 8.18x forward PE is well below the high-teens multiples staples peers often command, and the 5.10x price-to-cash-flow ratio suggests cash generation is cheaply valued. However, the trailing PE of -4.31x is not meaningful due to the impairment-driven loss, and the discount is partly justified by negative revenue growth and margin compression. The market is pricing TAP as a value trap, implying it expects persistent volume declines; a stabilization in volumes would likely trigger a re-rating toward the $44-$55 range.
From a risk/reward perspective, TAP offers modest upside of +11.5% to the analyst average target of $44.05, plus a 4.13% dividend yield, against downside of about -16.5% to the analyst low target of $33.00. The 0.82x sales multiple and 8.18x forward PE provide a valuation floor, but revenue is contracting 3.26% and gross margin has compressed 571 basis points, so the risk/reward is balanced rather than compelling. It is a good buy for income-focused value investors who can tolerate near-term volatility and a possible dividend cut, but growth investors should look elsewhere. The stock is best accumulated on weakness toward the $35.52 52-week low rather than chased at current levels.
TAP is better suited for long-term income-oriented holding than short-term trading. Its beta of 0.43 means it lacks the volatility that short-term traders seek, and the 4.13% dividend yield rewards patience while the volume cycle plays out. The stock is in a mature, structurally challenged category with negative revenue growth, so earnings visibility is limited and a multi-year turnaround may be required. A suggested minimum holding period is 18-24 months, allowing time for volume stabilization and margin recovery to materialize, with position sizing that accounts for the binary outcome around earnings and the risk of a dividend cut.